Coordinatore | HELSINGIN YLIOPISTO
Organization address
address: YLIOPISTONKATU 4 contact info |
Nazionalità Coordinatore | Finland [FI] |
Totale costo | 7˙895˙271 € |
EC contributo | 5˙999˙974 € |
Programma | FP7-KBBE
Specific Programme "Cooperation": Food, Agriculture and Biotechnology |
Code Call | FP7-KBBE-2009-3 |
Funding Scheme | CP-IP |
Anno di inizio | 2010 |
Periodo (anno-mese-giorno) | 2010-08-01 - 2014-07-31 |
# | ||||
---|---|---|---|---|
1 |
HELSINGIN YLIOPISTO
Organization address
address: YLIOPISTONKATU 4 contact info |
FI (HELSINGIN YLIOPISTO) | coordinator | 871˙883.00 |
2 |
KATHOLIEKE UNIVERSITEIT LEUVEN
Organization address
address: Oude Markt 13 contact info |
BE (LEUVEN) | participant | 645˙020.00 |
3 |
TEKNOLOGIAN TUTKIMUSKESKUS VTT
Organization address
address: TEKNIIKANTIE 4 A contact info |
FI (ESPOO) | participant | 529˙999.00 |
4 |
ABO AKADEMI
Organization address
address: DOMKYRKOTORGET 3 contact info |
FI (ABO) | participant | 384˙392.00 |
5 |
UNIVERSIDAD DE LA LAGUNA
Organization address
address: MOLINOS DE AGUA S/N contact info |
ES (LA LAGUNA TENERIFE) | participant | 359˙999.00 |
6 |
UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II.
Organization address
address: Corso Umberto I 40 contact info |
IT (NAPOLI) | participant | 359˙998.00 |
7 |
UNIVERZA V LJUBLJANI
Organization address
address: KONGRESNI TRG 12 contact info |
SI (LJUBLJANA) | participant | 350˙000.00 |
8 |
UNIVERSITE DE STRASBOURG
Organization address
address: rue Blaise Pascal 4 contact info |
FR (Strasbourg) | participant | 349˙998.00 |
9 |
UNIWERSYTET GDANSKI
Organization address
address: ul. Bazynskiego 1a contact info |
PL (GDANSK) | participant | 324˙999.00 |
10 |
XENTION LTD
Organization address
address: "Iconix Park, London Road, Pampisford" contact info |
UK (CAMBRIDGE) | participant | 308˙448.00 |
11 |
EGE UNIVERSITESI
Organization address
address: EGE UNIVERSITY KAMPUSU contact info |
TR (IZMIR) | participant | 299˙999.00 |
12 |
ACREO SWEDISH ICT AB
Organization address
address: ELECTRUM 236 contact info |
SE (KISTA) | participant | 230˙000.00 |
13 | Euroespes Bioetcnologia S.A. | ES | participant | 200˙000.00 |
14 |
American University of Beirut
Organization address
address: BLISS STREET contact info |
LB (BEIRUT) | participant | 199˙742.00 |
15 |
NATIONAL INSTITUTE OF OCEANOGRAPHY
Organization address
address: DONA PAULA contact info |
IN (GOA) | participant | 197˙998.00 |
16 |
UNIVERSIDAD CATOLICA DEL NORTE
Organization address
address: AVENIDA ANGAMOS 0610 contact info |
CL (ANTOFAGASTA) | participant | 123˙750.00 |
17 |
Universidad de Antofagasta
Organization address
address: Avenida Angamos 601 contact info |
CL (Antofagasta) | participant | 123˙750.00 |
18 |
BIOVICO SP ZOO
Organization address
address: UL. HRYNIEWICKIEGO 6B/135 contact info |
PL (GDYNIA) | participant | 90˙000.00 |
19 |
BIOTECHMARINE
Organization address
address: Zone industrielle de Quemper Guezennec contact info |
FR (PONTRIEUX) | participant | 49˙999.00 |
20 |
IMEGO AB
Organization address
address: Arvid Hedvalls backe 4 contact info |
SE (GOETEBORG) | participant | 0.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'Biodiversity in the seas is only partly explored, although marine organisms are excellent sources for many industrial products. Through close co-operation between industrial and academic partners, the MAREX project will collect, isolate and classify marine organisms, such as micro- and macroalgae, cyanobacteria, sea anemones, tunicates and fish from the Atlantic, Pacific and Indian Oceans as well as from the Mediterranean, Baltic and Arabian Seas. Extracts and purified compounds of these organisms will be studied for several therapeutically and industrially significant biological activities, including anticancer, anti-inflammatory, antiviral and anticoagulant activities by applying a wide variety of screening tools, as well as for ion channel/receptor modulation and plant growth regulation. Chromatographic isolation of bioactive compounds will be followed by structural determination. Sustainable cultivation methods for promising organisms, and biotechnological processes for selected compounds will be developed, as well as biosensors for monitoring the target compounds. The work will entail sustainable organic synthesis of selected active compounds and new derivatives, and development of selected hits to lead compounds. The project will expand marine compound libraries. MAREX innovations will be targeted for industrial product development in order to improve the growth and productivity of European marine biotechnology. MAREX aims at a better understanding of environmentally conscious sourcing of marine biotechnology products and increased public awareness of marine biodiversity and potential. Finally, MAREX is expected to offer novel marine-based lead compounds for European industries and strengthen their product portfolios related to pharmaceutical, nutraceutical, cosmetic, agrochemical, food processing, material and biosensor applications.'
Marine organisms are an excellent source of novel chemicals and enzymes, which include a variety of primary and secondary metabolites with significant biological activities. Variations within species can produce differences in compounds and in their concentrations in different marine environments. Therefore, it is essential to study organisms from various locations.
There is a constant need for new chemotherapeutics for treating human disease, particularly in the anti-infective, anticancer and anti-inflammatory fields. Therefore, the EU-funded http://www.marex.fi/ (MAREX) project investigated new compounds in natural products from marine organisms. The project involved researchers from all over the world who have collected marine organisms from seas and oceans in Asia, Europe and South America.
The consortium created a project database, established logistics protocols and conducted data collection covering e.g., sampling, processing, cultivation and biological testing procedures and results. Researchers also developed methods and techniques for the cultivation of several algae and bacterial species. In addition, species of algae, cyanobacteria and marine invertebrates were sampled and several interesting chemical compounds were isolated and characterized from extracts for further study.
Over 600 marine organisms were collected from the Atlantic, Indian and Pacific Oceans and from the Adriatic, Arabian, Baltic and Mediterranean Seas. These organisms included dinoflagellates and other microalgae, cyanobacteria, sponges, sea anemones, tunicates and sea cucumbers.
Samples with significant antimicrobial activity against bacteria and fungi were identified. This included combating the growth of methicillin-resistant Staphylococcus aureus. Scientists also identified samples active against other bacteria such as Vibrio cholerae, some strains of which cause the disease cholera.
The project also contributed to the design, synthesis and evaluation of around 400 new synthetic compounds based on natural products involved in alleviating cancer, bacterial infection and inflammation. Natural product extracts were also studied for their potential growth regulating activity against higher plants and microalgae. For example, extracts from the cyanobacterial species Nodularia were shown to control the growth of microalgae.
MAREX results confirmed the importance of using marine natural products as a starting point for the discovery of new drugs. The work helps to increase availability of bioactive compounds of marine origin and has strengthened the potential of the European pharmaceutical and chemical industry in drug discovery.